Improved tolerability of neratinib in patients with...

  • Main
  • 2020 / 5
  • Improved tolerability of neratinib in patients with...
Annals of Oncology 2020 / 5

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: diarrheal toxicity in the CONTROL trial

Barcenas, C.H., Hurvitz, S.A., Di Palma, J.A., Bose, R., Chien, A.J., Iannotti, N., Marx, G., Brufsky, A., Litvak, A., Ibrahim, E., Alvarez, R.H., Ruiz-Borrego, M., Chan, N., Manalo, Y., Kellum, A., T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.05.012
Date:
May, 2020
File:
PDF, 2.53 MB
2020
Conversion to is in progress
Conversion to is failed